Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-25-004233·Praxis Precision Medicines, Inc.
Schedule 13G ownership disclosure
Praxis Precision Medicines Inc
Common Stock, par value $0.0001 per share · CUSIP: 74006W207
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners III, L.P.
Shares: 1,190,340.00 · Class: 6.1%
- VHCP Co-Investment Holdings III, LLC
Shares: 1,190,340.00 · Class: 6.1%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 1,190,340.00 · Class: 6.1%
- VHCP Management III, LLC
Shares: 1,190,340.00 · Class: 6.1%
- VHCP Management EG, LLC
Shares: 1,190,340.00 · Class: 6.1%
- Nimish Shah
Shares: 1,190,340.00 · Class: 6.1%
- Bong Y Koh
Shares: 1,190,340.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-004233
- Form type
- SCHEDULE 13G/A
- Filer
- Praxis Precision Medicines, Inc.
- CIK
- CIK 1689548
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership